These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23052415)

  • 1. Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    Eur J Clin Pharmacol; 2013 Apr; 69(4):1041-2. PubMed ID: 23052415
    [No Abstract]   [Full Text] [Related]  

  • 2. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acne treatment and inflammatory bowel disease: what is the evidence?
    Alikhan A; Henderson GP; Becker L; Sciallis GF
    J Am Acad Dermatol; 2011 Sep; 65(3):650-654. PubMed ID: 21704420
    [No Abstract]   [Full Text] [Related]  

  • 4. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
    Mostow EN
    Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538
    [No Abstract]   [Full Text] [Related]  

  • 5. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
    Mobacken H; Sundström A; Vahlquist A
    Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic retinoids (acitretin, isotretinoin)].
    Berbis P
    Ann Dermatol Venereol; 2007 Dec; 134(12):935-41. PubMed ID: 18166914
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
    Sarifakioglu E; Onur O; Kart H; Yilmaz AE
    Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible association between isotretinoin and inflammatory bowel disease.
    Reddy D; Siegel CA; Sands BE; Kane S
    Am J Gastroenterol; 2006 Jul; 101(7):1569-73. PubMed ID: 16863562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin use and the risk of inflammatory bowel disease.
    Thakrar BT; Robinson NJ
    Am J Gastroenterol; 2011 May; 106(5):1000-2; author reply 1002-3. PubMed ID: 21540903
    [No Abstract]   [Full Text] [Related]  

  • 12. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life.
    Greydanus DE; Azmeh R; Cabral MD; Dickson CA; Patel DR
    Dis Mon; 2021 Apr; 67(4):101103. PubMed ID: 33041056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
    Reilly BK; Ritsema TS
    JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotretinoin: update on controversial issues.
    Prevost N; English JC
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotretinoin: controversies, facts, and recommendations.
    Bauer LB; Ornelas JN; Elston DM; Alikhan A
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 18. JAAD Game Changer: Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin.
    Brodell RT
    J Am Acad Dermatol; 2024 Jul; 91(1):90. PubMed ID: 37742841
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and treatment of acne.
    Bogal CB
    Adv Nurse Pract; 2010 Apr; 18(4):22. PubMed ID: 20486299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.